for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

Polarityte Inc

PTE.OQ

Latest Trade

1.03USD

Change

--(--)

Today's Range

--

 - 

--

52 Week Range

0.78

 - 

4.59

As of on the NASDAQ ∙ Minimum 15 minute delay

Pricing

Previous Close
1.03
Open
--
Volume
--
3M AVG Volume
11.25
Today's High
--
Today's Low
--
52 Week High
4.59
52 Week Low
0.78
Shares Out (MIL)
38.92
Market Cap (MIL)
43.98
Forward P/E
--
Dividend (Yield %)
--

Latest Developments

More

PolarityTE Expects Q3 Revenue To Meet Or Exceed High-End Of Guidance

PolarityTE Posts Quarterly Net Loss Per Share $0.33

PolarityTE Says Workforce Reduction Affected 31.7% Employees In Regenerative Medicine Business Segment

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up

About Polarityte Inc

PolarityTE, Inc., formerly Majesco Entertainment Company, is the owner of patent applications and know-how related to regenerative medicine and tissue engineering, as well as software applications used in diagnosis and treatment related to regenerative medicine. The Company seeks to develop and obtain regulatory approval for technology that will utilize a patient's own tissue substrates for the regeneration of skin, bone, muscle, cartilage, fat, blood vessels and nerves. The Company's PolarityTE platform simplifies regeneration and allows cells to function naturally. The platform can be applied across all cells, tissues and composite structures. The Company focuses on various products, including SkinTE, OsteoTE, AngioTE, MyoTE, CartTE, AdiposeTE and NeuralTE. The Company, through SkinTE, is focused on supplying an autologous construct to regenerate a patient’s skin due to a variety of injuries and conditions.

Industry

Biotechnology & Drugs

Contact Info

1960 S. 4250 West

SALT LAKE CITY, UT

84104

United States

+1.385.2372279

https://www.polarityte.com/

Executive Leadership

Peter A. Cohen

Independent Chairman of the Board

Richard Hague

President, Chief Operating Officer

David B. Seaburg

Chief Executive Officer, Director

Jacob Alexander Patterson

Interim Chief Financial Officer

Cameron J. Hoyler

General Counsel, Secretary, EVP - Corporate Development & Strategy

Key Stats

2.40 mean rating - 5 analysts
Sell
Hold
Buy
Revenue (MM, USD)

2018

0.0K

2019

0.0K

2020(E)

0.0K
EPS (USD)

2018

-4.860

2019

-3.700

2020(E)

-0.995
Price To Earnings (TTM)
--
Price To Sales (TTM)
7.26
Price To Book (MRQ)
1.47
Price To Cash Flow (TTM)
--
Total Debt To Equity (MRQ)
18.19
LT Debt To Equity (MRQ)
11.53
Return on Investment (TTM)
-116.72
Return on Equity (TTM)
-101.14

Latest News

Latest News

BRIEF-PolarityTE Says Workforce Reduction Affected 31.7% Employees In Regenerative Medicine Business Segment

* POLARITYTE INC - INITIATED A REDUCTION IN FORCE ON MAY 19, 2020, WITHIN COMPANY S REGENERATIVE MEDICINE BUSINESS SEGMENT

BRIEF-Gatemore Capital Management Llp Reports 6.5% Stake In Polarityte Inc As Of May 6

* GATEMORE CAPITAL MANAGEMENT LLP REPORTS 6.5% STAKE IN POLARITYTE INC AS OF MAY 6 - SEC FILING

BRIEF-Michael Brauser And Peter Benz Says On May 18, Counsel For Michael Brauser And Peter Benz Delivered Letter To Polarityte's Board

* MICHAEL BRAUSER AND PETER BENZ SAYS ON MAY 18, COUNSEL FOR MICHAEL BRAUSER AND PETER BENZ DELIVERED LETTER TO POLARITYTE INC'S BOARD - SEC FILING

BRIEF-Polarityte Reports First Quarter 2020 Results

* Q1 REVENUE $933,000 VERSUS REFINITIV IBES ESTIMATE OF $1 MILLION

BRIEF-Polarityte Provides Corporate Update Related To Covid-19 And Announces Preliminary First Quarter Results

* POLARITYTE PROVIDES CORPORATE UPDATE RELATED TO COVID-19 AND ANNOUNCES PRELIMINARY FIRST QUARTER RESULTS

BRIEF-Polarityte Announces Conclusion Of SEC Investigation

* POLARITYTE INC - SEC STAFF DOES NOT INTEND TO RECOMMEND AN ENFORCEMENT ACTION BY SEC AGAINST POLARITYTE

BRIEF-PolarityTE Announces Appointment Of David Seaburg As CEO And Restructuring Of Executive Team

* POLARITYTE ANNOUNCES APPOINTMENT OF DAVID SEABURG AS CEO AND RESTRUCTURING OF EXECUTIVE TEAM

BRIEF-Polarityte Q4 Revenue $1.466 Million Versus Refinitiv Ibes Estimate Of $1.6 Million

* Q4 REVENUE $1.466 MILLION VERSUS REFINITIV IBES ESTIMATE OF $1.6 MILLION

BRIEF-PolarityTE Announces Pricing Of Public Offering Of Common Stock And Warrants

* POLARITYTE ANNOUNCES PRICING OF PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

BRIEF-Polarityte Announces Public Offering Of Common Stock And Warrants

* POLARITYTE ANNOUNCES PUBLIC OFFERING OF COMMON STOCK AND WARRANTS

Quote and financial data from Refinitiv. Fund performance data provided by Lipper. All quotes delayed a minimum of 15 minutes.

for-phone-onlyfor-tablet-portrait-upfor-tablet-landscape-upfor-desktop-upfor-wide-desktop-up